|

Anti-CD19 CART cells will be given IV at split doses. Clinical Trials

1 actively recruiting trial

Top Sponsors

  • The First Affiliated Hospital of University of Science and Technology of China1

Indications

  • Arthritis1
  • Rheumatoid Arthritis1

Other1 trial

Safety and Efficacy of SWK002 in Patients With D2T-Rheumatoid Arthritis
N/A

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.